Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing
Authors
Keywords
Statins, Case-control studies, Metaanalysis, Musculoskeletal injury, Drug-drug interactions, Adverse reactions, Quality control, Rhabdomyolysis
Journal
PLoS One
Volume 14, Issue 6, Pages e0218115
Publisher
Public Library of Science (PLoS)
Online
2019-06-27
DOI
10.1371/journal.pone.0218115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs
- (2016) Xiaoming Liu et al. HUMAN MUTATION
- Rare variants in known and novel candidate genes predisposing to statin-associated myopathy
- (2016) Magdaléna Neřoldová et al. PHARMACOGENOMICS
- Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
- (2015) C. Dong et al. HUMAN MOLECULAR GENETICS
- Phenotype Standardization for Statin-Induced Myotoxicity
- (2014) A Alfirevic et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- GATM gene variants and statin myopathy risk
- (2014) D. F. Carr et al. NATURE
- GATM locus does not replicate in rhabdomyolysis study
- (2014) James S. Floyd et al. NATURE
- SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
- (2013) D F Carr et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Recommended Joint and Meta-Analysis Strategies for Case-Control Association Testing of Single Low-Count Variants
- (2013) Clement Ma et al. GENETIC EPIDEMIOLOGY
- A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
- (2013) Lara M. Mangravite et al. NATURE
- A Screening Study of Drug–Drug Interactions in Cerivastatin Users: An Adverse Effect of Clopidogrel
- (2012) J S Floyd et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cerivastatin, genetic variants, and the risk of rhabdomyolysis
- (2011) Kristin D. Marciante et al. Pharmacogenetics and Genomics
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy
- (2010) Andrew L. Mammen et al. ARTHRITIS AND RHEUMATISM
- METAL: fast and efficient meta-analysis of genomewide association scans
- (2010) C. J. Willer et al. BIOINFORMATICS
- Biological, clinical and population relevance of 95 loci for blood lipids
- (2010) Tanya M. Teslovich et al. NATURE
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Methods for Detecting Associations with Rare Variants for Common Diseases: Application to Analysis of Sequence Data
- (2008) Bingshan Li et al. AMERICAN JOURNAL OF HUMAN GENETICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started